HPV vaccine recommendations

Michael T. Brady; Carrie L. Byington; H. Dele Davies; Kathryn M. Edwards; Mary P. Glode; Mary Anne Jackson; Harry L. Keyserling; Yvonne A. Maldonado; Dennis L Murray; Walter A. Orenstein; Gordon E. Schutze; Rodney E. Willoughby; Theoklis E. Zaoutis

doi:10.1542/peds.2011-3865

HPV vaccine recommendations

Michael T. Brady
, Carrie L. Byington
, H. Dele Davies
, Kathryn M. Edwards
, Mary P. Glode
, Mary Anne Jackson
, Harry L. Keyserling
, Yvonne A. Maldonado
, Dennis L Murray
, Walter A. Orenstein
, Gordon E. Schutze
, Rodney E. Willoughby
, Theoklis E. Zaoutis

Pediatrics

Research output: Contribution to journal › Review article › peer-review

96 Scopus citations

Abstract

On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck & Co, Inc, Whitehouse Station, NJ) be used routinely in males. The American Academy of Pediatrics has reviewed updated data provided by the Advisory Committee on Immunization Practices on vaccine efficacy, safety, and cost-effectiveness as well as programmatic considerations and supports this recommendation. This revised statement updates recommendations for human papillomavirus immunization of both males and females.

Original language	English (US)
Pages (from-to)	602-605
Number of pages	4
Journal	Pediatrics
Volume	129
Issue number	3
DOIs	https://doi.org/10.1542/peds.2011-3865
State	Published - Mar 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Adolescents
Cancer
Females
HPV
Human papillomavirus
Immunization
Males
Vaccine

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1542/peds.2011-3865

Cite this

@article{c2d0fd8617a34df6978cf26272a03d50,

title = "HPV vaccine recommendations",

abstract = "On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck \& Co, Inc, Whitehouse Station, NJ) be used routinely in males. The American Academy of Pediatrics has reviewed updated data provided by the Advisory Committee on Immunization Practices on vaccine efficacy, safety, and cost-effectiveness as well as programmatic considerations and supports this recommendation. This revised statement updates recommendations for human papillomavirus immunization of both males and females.",

keywords = "Adolescents, Cancer, Females, HPV, Human papillomavirus, Immunization, Males, Vaccine",

author = "Brady, \{Michael T.\} and Byington, \{Carrie L.\} and Davies, \{H. Dele\} and Edwards, \{Kathryn M.\} and Glode, \{Mary P.\} and Jackson, \{Mary Anne\} and Keyserling, \{Harry L.\} and Maldonado, \{Yvonne A.\} and Murray, \{Dennis L\} and Orenstein, \{Walter A.\} and Schutze, \{Gordon E.\} and Willoughby, \{Rodney E.\} and Zaoutis, \{Theoklis E.\}",

year = "2012",

month = mar,

doi = "10.1542/peds.2011-3865",

language = "English (US)",

volume = "129",

pages = "602--605",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "3",

}

TY - JOUR

T1 - HPV vaccine recommendations

AU - Brady, Michael T.

AU - Byington, Carrie L.

AU - Davies, H. Dele

AU - Edwards, Kathryn M.

AU - Glode, Mary P.

AU - Jackson, Mary Anne

AU - Keyserling, Harry L.

AU - Maldonado, Yvonne A.

AU - Murray, Dennis L

AU - Orenstein, Walter A.

AU - Schutze, Gordon E.

AU - Willoughby, Rodney E.

AU - Zaoutis, Theoklis E.

PY - 2012/3

Y1 - 2012/3

N2 - On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck & Co, Inc, Whitehouse Station, NJ) be used routinely in males. The American Academy of Pediatrics has reviewed updated data provided by the Advisory Committee on Immunization Practices on vaccine efficacy, safety, and cost-effectiveness as well as programmatic considerations and supports this recommendation. This revised statement updates recommendations for human papillomavirus immunization of both males and females.

AB - On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck & Co, Inc, Whitehouse Station, NJ) be used routinely in males. The American Academy of Pediatrics has reviewed updated data provided by the Advisory Committee on Immunization Practices on vaccine efficacy, safety, and cost-effectiveness as well as programmatic considerations and supports this recommendation. This revised statement updates recommendations for human papillomavirus immunization of both males and females.

KW - Adolescents

KW - Cancer

KW - Females

KW - HPV

KW - Human papillomavirus

KW - Immunization

KW - Males

KW - Vaccine

UR - https://www.scopus.com/pages/publications/84857951007

UR - https://www.scopus.com/pages/publications/84857951007#tab=citedBy

U2 - 10.1542/peds.2011-3865

DO - 10.1542/peds.2011-3865

M3 - Review article

C2 - 22371460

AN - SCOPUS:84857951007

SN - 0031-4005

VL - 129

SP - 602

EP - 605

JO - Pediatrics

JF - Pediatrics

IS - 3

ER -

HPV vaccine recommendations

Abstract

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this